FIELD: medicine, pharmacology, pharmacy. SUBSTANCE: invention relates to novel radiopharmaceutical compositions. Composition comprises radioactive salt of pyrophosphoric acid in combination with pharmaceutically acceptable carrier. Invention provides also novel radiopharmaceutical compositions comprising radioactive salt of pyrophosphoric acid in combination with one or more amount of polymeric resins. Compositions and matrices are useful for their using in methods of treatment including brachytherapy. Invention provides decrease of radioactivity amount with respect to that cancer tissue is subjected for treatment. EFFECT: valuable properties of compositions and matrices. 65 cl, 9 tbl, 25 dwg, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES OF FLUORENE | 1992 |
|
RU2051151C1 |
| CYCLIC PEPTIDES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2096415C1 |
| POLYCYCLIC COMPOUNDS, THEIR DERIVATIVES, PHARMACEUTICAL PREPARATIONS AS ENHANCERS AND METHOD OF TREATMENT OF INTELLECTUAL ACTIVITY DISORDER | 1994 |
|
RU2152944C1 |
| ANTHRAPYRAZOLONE DERIVATIVES, METHODS OF THEIR SYNTHESIS AND METHODS OF SYNTHESIS OF ANTHRAPYRAZOLONES FROM THEIR SHOWING ANTITUMOR ACTIVITY | 1994 |
|
RU2142456C1 |
| CARBOCYCLIC AND HETEROCYCLIC CONDENSED COMPOUNDS OF QUINOLINE CARBOXYLIC ACID SUITED AS IMMUNODEPRESSANTS | 1994 |
|
RU2133740C1 |
| RADIOPHARMACEUTICAL COMPOSITION AND METHODS OF ITS PREPARING | 1991 |
|
RU2095085C1 |
| CYCLIC UREAS, METHOD OF INHIBITION OF RETROVIRUS GROWTH AND PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2131420C1 |
| RADIOACTIVE SOURCE FOR BRACHYTHERAPY, METHOD OF MAKING THE DEVICE (VERSIONS), METHOD OF TREATMENT BY USING THE DEVICE AND COMPOSITION ON ITS BASE | 1999 |
|
RU2251437C2 |
| ISOXAZOLINES AND ISOXAZOLES, METHOD OF INHIBITION OF PLATELET AGGREGATION, PHARMACEUTICAL COMPOSITION INHIBITING PLATELET AGGREGATION | 1994 |
|
RU2149871C1 |
| METHOD FOR PRODUCING RADIOLABELLED CALCIUM CARBONATE PARTICLES USING DEFEROXAMINE AS CHELATING AGENT | 2022 |
|
RU2806148C1 |
